The strategic partnership represents the next-gen approach to bridging science with rapid go-to-market strategies.
SRI and Global Innovation Labs (GIL), a newly launched venture fund and commercialization platform, formed a strategic partnership to accelerate breakthrough technologies from lab to market.
GIL will extend SRI’s venture creation footprint by operating a network of regional commercialization and investment hubs in innovation-driven economies, beginning with hubs in the U.S., Korea, Japan, and Singapore. GIL will oversee global commercialization and fund management for each hub, and SRI will license its intellectual property (IP) to regional startups.
“SRI has a long and successful history of transforming bold ideas into world-changing innovations,” said Peter Marcotullio, vice president of commercialization for SRI. “The relationship with GIL allows us to extend that capability even further — building regional venture ecosystems that bring our science and deep tech to market faster and more effectively.”
“This collaboration allows us to build integrated innovation ecosystems where research, venture capital, and market expertise converge to transform scientific discoveries into thriving companies.” — Todd Stavish
SRI and GIL will work with governments, corporations, and institutional investors in various regions to co-develop strategic technologies across AI, quantum, advanced materials, robotics, biotechnology, healthcare, and more. Each hub will serve as a launchpad for startups, research translation, and talent development — building on SRI’s proven and impactful mission.
“More than a venture fund, Global Innovation Labs is a platform to translate scientific breakthroughs into globally competitive enterprises,” said David Park, general partner of GIL. “By tying together SRI’s deep R&D expertise with the emerging strengths of local ecosystems, we can accelerate the creation of companies that solve real-world challenges and scale across borders.”
The SRI ventures team works with entrepreneurs looking to address significant market needs and make a substantial impact, launching an average of ten ventures per year. SRI’s track record of successful ventures spans areas such as aerospace, automation, AI, drug discovery, robotics, and geospatial. SRI’s ventures portfolio includes companies like Siri (acquired by Apple), Leo Labs, and Intuitive Surgical.
“This collaboration allows us to build integrated innovation ecosystems where research, venture capital, and market expertise converge to transform scientific discoveries into thriving companies,” said Todd Stavish, vice president of SRI’s ventures group. “This partnership creates a multiplier effect — enabling us to launch more ventures, faster, while building innovation ecosystems that drive regional economic growth.”
Learn more about Global Innovation Labs or explore how SRI helps startups innovate by connecting with SRI’s ventures team.
